FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896232007> ?p ?o ?g. }

• W2896232007 endingPage "2423" @default.
• W2896232007 startingPage "2417" @default.
• W2896232007 abstract "Background: Unfractionated heparin (UFH), despite its limitations, has been used as the primary anticoagulant alternative during the percutaneous coronary intervention (PCI). Some studies indicated that intravenous enoxaparin could be an effective and safe option. Our team used enoxaparin alone at one time according to the guidelines (Class IIA) and found a little catheter thrombosis during PCI. We recommend a new anticoagulation strategy using enoxaparin in combination with UFH. Enoxaparin has a more predictable anticoagulant response with no need of repeatedly monitoring anticoagulation during PCI. This retrospective study aimed to evaluate the efficacy and safety of using enoxaparin in combination with UFH in PCI patients with complex coronary artery disease. Methods: Between January 2015 and April 2017, 600 PCI patients who received intravenous UFH at an initial dose of 3000 U plus intravenous enoxaparin at a dose of 0.75 mg/kg (observation group) and 600 PCI patients who received UFH at a dose of 100 U/kg (control group) were consecutively included in this retrospective study. The endpoints were postoperative 48-h thrombolysis in myocardial infarction (TIMI) bleeding and transfusion and 30-day and 1-year major adverse cardio-cerebrovascular events (MACCE). Results: Baseline clinical, angiographic, and procedural characteristics were similar between groups, except there was less stent implantation per patient in the observation group (2.13 vs. 2.25 in the control group, P = 0.002). TIMI bleeding (3.3% vs. 4.7%) showed no significant difference between the observation group and control group. During the 30-day follow-up, the rate of MACCE was 0.9% in the observation group and 1.5% in the control group. There was no significant difference in the rates of MACCE, death, myocardial infarction, target vessel revascularization, cerebrovascular event, and angina within 30 days and 1 year after PCI between groups as well as in the subgroup analysis of transfemoral approach. Conclusions: UFH with sequential enoxaparin has similar anticoagulant effect and safety as UFH in PCI of complex coronary artery disease." @default.
• W2896232007 created "2018-10-26" @default.
• W2896232007 creator A5009124230 @default.
• W2896232007 creator A5011723711 @default.
• W2896232007 creator A5020919407 @default.
• W2896232007 creator A5039209940 @default.
• W2896232007 creator A5055871424 @default.
• W2896232007 creator A5070011429 @default.
• W2896232007 creator A5077902123 @default.
• W2896232007 creator A5091904163 @default.
• W2896232007 date "2018-10-20" @default.
• W2896232007 modified "2023-09-25" @default.
• W2896232007 title "Unfractionated Heparin with Sequential Enoxaparin in Patients with Complex Coronary Artery Lesions during Percutaneous Coronary Intervention" @default.
• W2896232007 cites W117662345 @default.
• W2896232007 cites W1544067555 @default.
• W2896232007 cites W158276933 @default.
• W2896232007 cites W1840021307 @default.
• W2896232007 cites W1983126671 @default.
• W2896232007 cites W1991588150 @default.
• W2896232007 cites W2003919909 @default.
• W2896232007 cites W2018776013 @default.
• W2896232007 cites W2019193038 @default.
• W2896232007 cites W2038706245 @default.
• W2896232007 cites W205369167 @default.
• W2896232007 cites W2076416344 @default.
• W2896232007 cites W2095901832 @default.
• W2896232007 cites W2108808603 @default.
• W2896232007 cites W2112380741 @default.
• W2896232007 cites W2127489984 @default.
• W2896232007 cites W2141192690 @default.
• W2896232007 cites W2283985353 @default.
• W2896232007 cites W2560640064 @default.
• W2896232007 cites W2586619765 @default.
• W2896232007 cites W2590563478 @default.
• W2896232007 cites W2808213141 @default.
• W2896232007 cites W4252057047 @default.
• W2896232007 cites W4293372203 @default.
• W2896232007 doi "https://doi.org/10.4103/0366-6999.243559" @default.
• W2896232007 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6202601" @default.
• W2896232007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30334526" @default.
• W2896232007 hasPublicationYear "2018" @default.
• W2896232007 type Work @default.
• W2896232007 sameAs 2896232007 @default.
• W2896232007 citedByCount "2" @default.
• W2896232007 countsByYear W28962320072020 @default.
• W2896232007 countsByYear W28962320072021 @default.
• W2896232007 crossrefType "journal-article" @default.
• W2896232007 hasAuthorship W2896232007A5009124230 @default.
• W2896232007 hasAuthorship W2896232007A5011723711 @default.
• W2896232007 hasAuthorship W2896232007A5020919407 @default.
• W2896232007 hasAuthorship W2896232007A5039209940 @default.
• W2896232007 hasAuthorship W2896232007A5055871424 @default.
• W2896232007 hasAuthorship W2896232007A5070011429 @default.
• W2896232007 hasAuthorship W2896232007A5077902123 @default.
• W2896232007 hasAuthorship W2896232007A5091904163 @default.
• W2896232007 hasBestOaLocation W28962320071 @default.
• W2896232007 hasConcept C126322002 @default.
• W2896232007 hasConcept C141071460 @default.
• W2896232007 hasConcept C164705383 @default.
• W2896232007 hasConcept C2776335557 @default.
• W2896232007 hasConcept C2776884760 @default.
• W2896232007 hasConcept C2777557582 @default.
• W2896232007 hasConcept C2777995511 @default.
• W2896232007 hasConcept C2778205648 @default.
• W2896232007 hasConcept C2778213512 @default.
• W2896232007 hasConcept C2778825682 @default.
• W2896232007 hasConcept C2779581417 @default.
• W2896232007 hasConcept C2780400711 @default.
• W2896232007 hasConcept C42219234 @default.
• W2896232007 hasConcept C45393284 @default.
• W2896232007 hasConcept C500558357 @default.
• W2896232007 hasConcept C71924100 @default.
• W2896232007 hasConceptScore W2896232007C126322002 @default.
• W2896232007 hasConceptScore W2896232007C141071460 @default.
• W2896232007 hasConceptScore W2896232007C164705383 @default.
• W2896232007 hasConceptScore W2896232007C2776335557 @default.
• W2896232007 hasConceptScore W2896232007C2776884760 @default.
• W2896232007 hasConceptScore W2896232007C2777557582 @default.
• W2896232007 hasConceptScore W2896232007C2777995511 @default.
• W2896232007 hasConceptScore W2896232007C2778205648 @default.
• W2896232007 hasConceptScore W2896232007C2778213512 @default.
• W2896232007 hasConceptScore W2896232007C2778825682 @default.
• W2896232007 hasConceptScore W2896232007C2779581417 @default.
• W2896232007 hasConceptScore W2896232007C2780400711 @default.
• W2896232007 hasConceptScore W2896232007C42219234 @default.
• W2896232007 hasConceptScore W2896232007C45393284 @default.
• W2896232007 hasConceptScore W2896232007C500558357 @default.
• W2896232007 hasConceptScore W2896232007C71924100 @default.
• W2896232007 hasIssue "20" @default.
• W2896232007 hasLocation W28962320071 @default.
• W2896232007 hasLocation W28962320072 @default.
• W2896232007 hasLocation W28962320073 @default.
• W2896232007 hasLocation W28962320074 @default.
• W2896232007 hasLocation W28962320075 @default.
• W2896232007 hasLocation W28962320076 @default.
• W2896232007 hasOpenAccess W2896232007 @default.
• W2896232007 hasPrimaryLocation W28962320071 @default.
• W2896232007 hasRelatedWork W2127687375 @default.

• next